Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Edetate Calcium Disodium
Brand Name
Edetate Calcium Disodium
Generic Name
Edetate Calcium Disodium
Active Ingredient
EdetateCategory
Non-Standardized Chemical Allergen [EPC]
Salt Form
Disodium
Variants
1
Different strengths and dosage forms
| Strength | Form | Route | NDC |
|---|---|---|---|
| 200 mg/mL | INJECTION | INTRAMUSCULAR, INTRAVENOUS | 64980-588 |
Detailed information about Edetate Calcium Disodium
This page is for informational purposes only and does not replace medical advice. Before using any prescription or over-the-counter medication for Edetate Calcium Disodium, you must consult a qualified healthcare professional.
Edetate, specifically Edetate Disodium, is a potent chelating agent used historically for hypercalcemia and digitalis toxicity, and currently recognized as a non-standardized chemical allergen in dermatological testing.
Dosage of Edetate Disodium must be meticulously calculated and individualized based on the patient's weight, renal function, and the severity of the condition being treated.
Edetate Disodium must be used with extreme caution in pediatric populations.
Edetate is primarily eliminated by the kidneys. In patients with any degree of renal insufficiency (elevated creatinine or reduced GFR), the dose must be significantly reduced, or the drug should be avoided entirely. Accumulation of the drug can lead to acute tubular necrosis (kidney failure).
Since Edetate is not metabolized by the liver, dosage adjustments based solely on hepatic function are generally not required. However, many patients with liver disease also have secondary renal issues, which must be assessed.
Geriatric patients are more likely to have undiagnosed renal impairment and lower physiological reserves. Healthcare providers typically start at the lowest end of the dosing range and monitor kidney function and cardiac rhythm closely throughout the infusion.
Edetate Disodium is not a medication you take at home. It is administered exclusively by healthcare professionals in a controlled clinical environment.
Because Edetate is administered in a hospital setting for acute conditions, missed doses are rare. If an infusion is interrupted, the healthcare provider will determine the best course of action based on current serum calcium levels. Patients should not attempt to 'double up' or catch up on doses independently.
An overdose of Edetate Disodium is a life-threatening event characterized by profound hypocalcemia.
> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose without medical guidance. Systemic EDTA therapy is a high-alert procedure.
When administered systemically, Edetate Disodium frequently causes reactions related to its chemical properties and its effect on electrolytes:
> Warning: Stop taking Edetate and call your doctor immediately if you experience any of these.
Edetate is typically used for short-term, emergency stabilization. However, if used repeatedly (as seen in some controversial 'alternative' chelation protocols), long-term risks include:
While Edetate Disodium does not always carry a traditional 'Black Box' in the same way modern antidepressants do, the FDA issued a Public Health Advisory in 2008 that serves the same function. The warning emphasizes:
Report any unusual symptoms to your healthcare provider. Monitoring of serum electrolytes is mandatory during treatment.
Edetate Disodium is classified as a high-alert medication. This means that if it is used incorrectly, it carries a significant risk of causing serious patient harm. The most critical safety point is the distinction between Edetate Disodium and Edetate Calcium Disodium. Patients and caregivers must be aware that these are not interchangeable.
No formal FDA black box warning exists in the traditional boxed format, but the 2008 FDA Public Health Advisory acts as the highest level of warning. It states that Edetate Disodium has been linked to fatal cases of hypocalcemia, particularly in children and the elderly, due to its potent calcium-binding properties. The FDA recommends that hospitals and clinics implement strict protocols to prevent the accidental administration of the disodium salt when the calcium disodium salt was intended.
Patients receiving systemic Edetate require intensive monitoring:
Because Edetate can cause dizziness, faintness, and blurred vision, patients should not drive or operate heavy machinery for at least 24 hours following an infusion. Most patients receiving this drug will be hospitalized and under restricted activity anyway.
Alcohol should be avoided during and immediately after Edetate therapy. Alcohol can dehydrate the body and strain the kidneys, potentially increasing the risk of Edetate-induced nephrotoxicity. Furthermore, alcohol can mask the early signs of electrolyte imbalance, such as dizziness or confusion.
Edetate therapy is usually short-term. There is no 'withdrawal syndrome' associated with stopping Edetate, but the underlying condition (such as hypercalcemia) must be monitored to ensure it does not rebound once the chelation effect wears off.
> Important: Discuss all your medical conditions, especially kidney or heart problems, with your healthcare provider before starting Edetate.
Edetate can significantly interfere with various laboratory tests by binding to the metal ions required for the chemical reactions in the lab:
For each major interaction, the mechanism usually involves either a pharmacodynamic effect (competing for the same physiological endpoint, like heart rhythm) or a chelation mechanism (physically binding to the other substance or its required co-factors).
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking, including over-the-counter eye drops which may contain EDTA.
There are several conditions where the use of Edetate Disodium is strictly prohibited due to the extreme risk of harm:
In these cases, the healthcare provider must perform a careful risk-benefit analysis:
Patients who have had an allergic reaction to other forms of EDTA (such as Edetate Calcium Disodium or Edetate Tetrasodium) are highly likely to react to Edetate Disodium. This cross-sensitivity extends to many consumer products. If you have been told you have a 'preservative allergy' related to eye drops or cosmetics, you must inform your doctor before receiving any form of Edetate.
> Important: Your healthcare provider will evaluate your complete medical history, including your kidney function and current electrolyte status, before prescribing Edetate.
Edetate Disodium is classified under FDA Pregnancy Category C. This means that animal reproduction studies have shown an adverse effect on the fetus, but there are no adequate and well-controlled studies in humans.
It is not known whether Edetate Disodium is excreted in human milk. However, because many drugs are excreted in milk and because of the potential for EDTA to strip essential minerals from the nursing infant, caution should be exercised.
As noted in the dosage section, pediatric use is fraught with risk.
Elderly patients are at the highest risk for adverse effects from Edetate.
In patients with renal impairment, Edetate is generally contraindicated. If it must be used, the dose must be reduced by at least 50% for mild impairment, and it should be avoided entirely in moderate to severe cases (Creatinine Clearance < 50 mL/min). Dialysis does not efficiently remove EDTA, so it cannot be relied upon to clear the drug in patients with kidney failure.
While the liver is not the primary organ for Edetate clearance, patients with severe hepatic disease (Child-Pugh Class C) often have altered fluid distribution and co-existing renal issues (hepatorenal syndrome). In these patients, the risk of fluid overload during the 500 mL infusion must be balanced against the clinical need.
> Important: Special populations require individualized medical assessment and often require lower doses and more frequent lab testing.
Edetate Disodium is a chelating agent that functions as a molecular 'trap' for metal ions. Chemically, it is a substituted ethylenediamine. The mechanism involves the formation of coordinate covalent bonds between the four carboxyl groups and two nitrogen atoms of the EDTA molecule and a single polyvalent metal ion.
In the blood, Edetate Disodium has a specific affinity sequence. It binds most strongly to lead, but in the absence of heavy metal excess, its primary target is ionized calcium. By sequestering calcium into a stable, ring-like structure (a chelate), the calcium is prevented from participating in biological processes, such as muscle contraction and nerve impulse transmission. This complex is highly water-soluble and is excreted through the kidneys.
| Parameter | Value |
|---|---|
| Bioavailability | <5% (Oral); 100% (IV) |
| Protein Binding | Minimal |
| Half-life | 20 - 60 minutes |
| Tmax | End of infusion |
| Metabolism | None (Excreted intact) |
| Excretion | Renal (95% within 24h) |
Edetate belongs to the class of Chelating Agents (Heavy Metal Antagonists). Related medications include Edetate Calcium Disodium (used for lead), Deferoxamine (used for iron), and Penicillamine (used for copper). Within the EPC (Established Pharmacologic Class) system, it is also categorized as a Non-Standardized Chemical Allergen when used for diagnostic skin testing.
Common questions about Edetate Calcium Disodium
Edetate, specifically Edetate Disodium, is primarily used for the emergency treatment of severe hypercalcemia (dangerously high calcium levels) and historically for heart rhythm problems caused by digitalis toxicity. It works by binding to calcium in the blood, allowing the body to flush it out through the urine. In modern dermatology, it is also used as a diagnostic tool in patch testing to identify patients with allergies to EDTA, which is a common preservative in household products. Because of its potency, it is only used when other, safer treatments are not effective or available. It is never used for routine health maintenance and must be administered by a doctor in a hospital setting.
The most common side effects of Edetate Disodium include pain and irritation at the injection site, nausea, and a general feeling of malaise or headache during the infusion. Because it rapidly removes calcium from the blood, patients may also feel lightheaded or dizzy. Some individuals develop a mild skin rash or hives as a reaction to the medication. More significantly, many patients experience a temporary drop in blood pressure during the treatment. It is essential to report any sensation of muscle cramping or tingling to your nurse immediately, as these can be early signs of a more serious reaction.
You should strictly avoid alcohol while receiving Edetate therapy and for several days afterward. Alcohol can cause dehydration and put additional strain on the kidneys, which are already working hard to filter the Edetate-calcium complex out of your system. Furthermore, alcohol can cause dizziness and interfere with your heart rhythm, potentially masking or worsening the side effects of the medication. Since Edetate is administered in a hospital for serious conditions, alcohol consumption is generally prohibited by hospital policy. Always consult your healthcare provider about when it is safe to resume alcohol consumption after your treatment is complete.
Edetate is classified as FDA Pregnancy Category C, meaning it is generally not recommended unless it is a life-threatening emergency. Animal studies have shown that high doses of EDTA can cause birth defects, likely by stripping the developing fetus of essential minerals like zinc. There is very limited data on the safety of Edetate in pregnant humans, so doctors will only use it if the mother's life is at risk from severe hypercalcemia. If you are pregnant or planning to become pregnant, you must discuss the potential risks to your baby with your medical team. Alternative treatments for high calcium are usually preferred during pregnancy.
When administered intravenously, Edetate begins working almost immediately to bind calcium in the bloodstream. However, the infusion itself must be given very slowly, usually over a period of 4 to 6 hours, to prevent a dangerously rapid drop in calcium levels. You may start to see a decrease in serum calcium levels on lab tests within a few hours of starting the infusion. The maximum effect is typically seen at the end of the infusion period. Because the body constantly regulates calcium, your doctor will continue to monitor your levels for several days to ensure they stay within a safe range.
Edetate is not a medication that you take on a long-term basis at home, so there is no risk of 'stopping' it in the traditional sense. It is given as a controlled infusion in a hospital. Once the prescribed dose is finished, the treatment ends. There are no withdrawal symptoms associated with Edetate. However, the underlying condition being treated, such as high calcium, must be monitored closely because it can sometimes return once the medication has left your system. Your doctor will determine if follow-up doses or different medications are needed based on your lab results.
Because Edetate is administered by healthcare professionals in a clinical setting, it is highly unlikely that you will miss a dose. If an infusion is delayed or interrupted for any reason, the medical staff will adjust the schedule and monitor your electrolytes to ensure your safety. You should never attempt to administer this medication to yourself or seek it outside of a legitimate medical facility. If you are participating in a clinical trial involving EDTA and miss an appointment, contact the study coordinator immediately for instructions on how to safely reschedule.
There is no clinical evidence to suggest that Edetate causes weight gain. The medication is used for short-term emergency treatment and does not affect the metabolic processes associated with fat storage or appetite. Some patients might experience temporary fluid retention or swelling (edema) because the medication is delivered in a large volume of IV fluid (usually 500 mL), but this is typically temporary and resolved once the kidneys excrete the fluid. If you notice sudden or significant weight gain after treatment, it could be a sign of kidney or heart issues and should be reported to your doctor immediately.
Edetate has several dangerous interactions with other medications, particularly those that affect the heart or kidneys. It should not be used with Cisplatin, as this can cause severe kidney damage, or with certain diuretics that already lower your mineral levels. If you are taking Digoxin, Edetate must be used with extreme caution because it can change how your heart reacts to the heart medicine. It is vital that you provide your doctor with a complete list of all medications, including vitamins and herbal supplements, before starting Edetate. Many supplements contain minerals that Edetate will bind to, making them ineffective.
Yes, Edetate Disodium is available as a generic medication, although its use has become much less common in recent years. Many brand-name versions have been discontinued in the United States due to the preference for newer, safer medications for hypercalcemia, such as bisphosphonates. However, generic EDTA is still widely used in laboratory settings, as a preservative in other medications, and in specialized diagnostic tests. If your doctor prescribes 'Edetate,' they are likely using a generic form of the salt tailored for your specific medical need, such as an ophthalmic solution or an allergen patch.